Drug General Information

Drug Name
Rivaroxaban
Synonyms
XARELTO (TN)
Drug Type
Small molecular drug
Indications
Deep vein thrombosis [ICD-11: BD71]
Approved
Company
Bayer HealthCare Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development
Summary
Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.
Target
Coagulation factor Xa (F10)
Mechanism of Action: Modulator
T84631

Drug Chemical Infomation and External Links

Formula
C19H18ClN3O5S
Canonical SMILES
C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl
InChI
1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1
InChIKey
KGFYHTZWPPHNLQ-AWEZNQCLSA-N
CAS Number CAS 366789-02-8
TTD ID D0KG3R
DrugBank ID DB06228
PubChem Compound ID 9875401
PubChem Substance ID
ChEBI ID CHEBI:68579
ADReCS Drug ID BADD_D01954

Drug-Food (Herb) Interactions

  • Drug
  • Foods
  • Herbs
  • Positive
  • Negative
  • Possible
  • Harmful
  • No Effect
ID Name Dose Type Drug Brand Name Drug Dose Drug Dosage Form Experimental Species Individuals Number Test Sample Ingredient Effect Relationship Classification
ID Name Dose Type Drug Brand Name Drug Dose Drug Dosage Form Experimental Species Individuals Number Test Sample Ingredient Effect Relationship classification